Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 10/2008

01-10-2008 | Editorial

What do we know about fatigue?

Author: Victor T. Chang

Published in: Supportive Care in Cancer | Issue 10/2008

Login to get access

Excerpt

Fatigue is experienced by patients in many phases of cancer—at presentation, with chemotherapy, with radiation therapy, after surgery, in survivors, and in advanced cancer. The universality of fatigue as a symptom and its effects on the quality of life in patients with advanced cancer [Lundh Hagelin C, Seiger A, Furst CJ, Quality of life in terminal care—with special reference to age, gender, and marital status, Support Care Cancer 14:320–8, 2006] makes it important, but fatigue has been a very difficult symptom to define and study. …
Literature
1.
Ryan JL, Carrol JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancer-related fatigue. Oncologist 12 Suppl 1:22–34
2.
Olson K, Turner AR, Courneya KS, Field C, Man G, Cree M, Hanson J (2008) Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Care Cancer 16:241–249PubMedCrossRef
3.
Okuyama T, Akechi T, Shima Y, Sugahara Y, Okamura H, Hosaka T, Furukawa T, Uchitomi Y (2008) Factors correlated with fatigue in the terminally ill: a longitudinal study. J Pain Symptom Manage 35:515–523PubMedCrossRef
Metadata
Title
What do we know about fatigue?
Author
Victor T. Chang
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0483-4

Other articles of this Issue 10/2008

Supportive Care in Cancer 10/2008 Go to the issue

Erratum

Impact of skeletal complications on patients’ quality of life, mobility, and functional independence

Original Article

The nature of small intestinal mucositis: a video-capsule endoscopy study

Original Article

Can the caregiver replace his/her elderly cancer patient in the physician–patient line of communication?

Original Article

A study of work changes due to cancer in tumor-free primary-treated cancer patients. A NOCWO study

Original Article

A randomized, double-blind, placebo-controlled trial of a β-hydroxyl β-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)

Original Article

Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits